Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases

Published:2024-05 Issue:10 Volume:162 Page:470-476
ISSN:2387-0206
Container-title:Medicina Clínica (English Edition)
language:en
Short-container-title:Medicina Clínica (English Edition)

Author:

Romero-Bogado Liz,Steiner Martina,Vasallo Israel John Thuissard,Vázquez Cristina Andreu,Navío Teresa,Muñoz-Fernández Santiago

Publisher

Elsevier BV

Reference33 articles.

1. Clinical characteristics of coronavirus disease 2019 in China;Guan;N Engl J Med,2020

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet.,2020

3. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents;Gembardt;Peptides.,2005

4. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa;Xu;Int J Oral Sci.,2020

5. What can we do to prevent infections in adult patients with rheumatic diseases?;Richi;J Vasc,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP